1. Rak R, Polonsky M, Eizenberg-Magar I, Mo Y, Sakaguchi Y, Mizrahi O, et al. Dynamic changes in tRNA modifications and abundance during T cell activation. PNAS (2021) Read

2. Hefetz N, Dahan O, Frumkin I, Pilpel Y, Rak R. Manipulation of the human tRNA pool reveals distinct tRNA sets that act in cellular proliferation or cell cycle arrest. Elife (2020) Read

3. Mordret E, Dahan O, Asraf O, Rak R, Yehonadav A, Barnabas G.D, Cox J, Geiger T, Lindner A.B, Pilpel Y. Systematic detection of amino acid substitutions in proteome reveals a mechanistic basis of ribosome errors and selection for translation fidelity. Molecular Cell (2019) Read

4. Kaminski Strauss S, Schirman D, Jona G, Brooks AN, Kunjapur AM, Rak R, et al. Evolthon: A community endeavor to evolve lab evolution. PLOS Biology (2019) Read

5. Rak R*, Dahan O*, Pilpel Y. Repertoires of tRNAs: The Couplers of Genomics and Proteomics. Annual Review of Cell and Developmental Biology (2018) Read

6. Sagi D*/**, Rak R*/**, Gingold H*, Adir I, Maayan G, Dahan O, Broday L, Pilpel Y, Rechavi O**. Tissue- and Time-Specific Expression of Otherwise Identical tRNA Genes. PLOS Genetics (2016) Read

7. Rak R, Kloog Y. Targeting LIM kinase in cancer and neurofibromatosis. Cell Cycle (2014) Read

8. Rak R, Elad-Sfadia G, Haklai R, Carmeli S, Wolfson H, Kloog Y. Novel LIMK2 inhibitor blocks pancreatic cancer growth in mice xenograft model. Oncoscience (2014) Read

9. Mashiach Farkash E*, Rak R*, Elad-Sfadia G, Haklai R, Carmeli S, Kloog Y, Wolfson H. Computer-Based Identification of a Novel LIMK1/2 Inhibitor that Synergizes with Salirasib to Destabilize the Actin Cytoskeleton. Oncotarget (2012) Read

* equal contributor **corresponding author

​